Cargando…
The first second-generation adenosine drug enters the US market
Autores principales: | Pelleg, Amir, Belardinelli, Luiz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583212/ https://www.ncbi.nlm.nih.gov/pubmed/18566916 http://dx.doi.org/10.1007/s11302-008-9114-2 |
Ejemplares similares
-
Adenosine Receptors in the Lungs
por: Pelleg, Amir, et al.
Publicado: (2018) -
Adenosine 5’-triphosphate’s role in bradycardia and syncope associated with pulmonary embolism
por: Pelleg, Amir, et al.
Publicado: (2018) -
First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010) -
Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
por: Zhou, Yang, et al.
Publicado: (2010) -
Effects of the COVID-19 pandemic on the US stock market and uncertainty: A comparative assessment between the first and second waves
por: Yousfi, Mohamed, et al.
Publicado: (2021)